Family physicians are optimally positioned to introduce NaProTECHNOLOGY to patients presenting with infertility, irregular cycles, or recurrent pregnancy loss during routine primary care, enabling early evaluation and restorative treatment before referral to subspecialists. Familiarity with CrMS charting interpretation, basic hormone panels timed to identified cycle phases, and the range of treatable NaPro diagnoses allows the family physician to substantially expand reproductive care at the primary care level.
how does NaProTechnology treat infertility, what is the success rate of NaProTechnology, NaProTechnology consultation what to expect, family doctor fertility treatment without IVF, Creighton Model charting for infertility diagnosis, is NaProTechnology effective after failed fertility treatment, fertility treatment success after age 40, restorative reproductive medicine fertility evaluation
Cite this article
Hilgers, T. W., & Boyle, P. C. (2004). Chapter 49: Family Physician's Approach. The Medical and Surgical Practice of NaProTECHNOLOGY, 653-666.
Hilgers TW, Boyle PC. Chapter 49: Family Physician's Approach. The Medical and Surgical Practice of NaProTECHNOLOGY. 2004:653-666.
Hilgers, T. W., and P. C. Boyle. "Chapter 49: Family Physician's Approach." The Medical and Surgical Practice of NaProTECHNOLOGY, 2004, pp. 653-666.
Related articles
InfertilityMultifactorial DiagnosisCycle Classification and Hormonal CorrelationLuteinized Unruptured Follicle and Serial Ultrasound
Hilgers TW, 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
NaProTECHNOLOGY applies the standardized biomarkers of the Creighton Model FertilityCare System to identify the specific pathophysiological causes of infertility in each couple, then directs targeted medical or surgical intervention against those causes. Published pregnancy rates demonstrate outcomes comparable to or exceeding IVF in many diagnostic categories, without the ethical, financial, or obstetric risks associated with assisted reproduction.
Hilgers TW, 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
The CREIGHTON MODEL FertilityCare System (CrMS) rests on a decades-long body of research demonstrating that cervical mucus functions as a physiologically regulated biological valve, opening predictably at the periovulatory estrogen rise and closing in the post-Peak phase. Chapter 15 of Hilgers (2004) synthesizes hormonal, ultrasound, cytologic, and biophysical evidence to establish that a woman's external observation of her Peak Day reliably identifies the fertile window, and documents the system's effectiveness data for both achieving and avoiding pregnancy across a five-study meta-analysis of nearly 1,900 couples.
PCOSEpidemiology and PrevalenceMetabolic ReframeDefective Ovulatory Events
Hilgers TW, 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
PCOS (polycystic ovary syndrome), increasingly designated PMOS (polycystic metabolic ovary syndrome) to reflect its metabolic complexity, is far more prevalent than its classic presentation suggests, affecting roughly six percent of reproductive-age women and carrying systemic consequences well beyond fertility disruption. This chapter from the foundational NaProTECHNOLOGY textbook maps the hormonal architecture of the condition, its ovulatory defect patterns, its frequent co-occurrence with endometriosis, and the restorative surgical and cycle-tracking approaches developed at the Pope Paul VI Institute.